Literature DB >> 25062758

Antiepileptic medications increase osteoporosis risk in male fabry patients: bone mineral density in an Australian cohort.

Andrew Talbot1, Joanna R Ghali, Kathy Nicholls.   

Abstract

BACKGROUND: Fabry disease (FD) is an inherited X-linked lysosomal storage disease with widespread clinical manifestations. Small prospective studies have shown increased osteopenia and osteoporosis in male FD patients. Limited information however exists about bone metabolism and osteoporosis risk factors within this group. We reviewed osteoporosis risk factors within our cohort.
METHODS: A retrospective analysis of bone mineral density (BMD) results and fracture incidence in 44 patients (22 males and 22 females) was undertaken. Dual X-ray absorptiometry scans were performed at the lumbar spine, hip and femoral neck. The impact of risk factors including renal function, antiepileptic drug (AED), analgesia and vitamin D levels were assessed.
RESULTS: Male FD patients had low T scores at all sites (spine -1.2 ± 1.06, hip -1.6 ± 0.9, femoral neck -2.23 ± 1.01). Female T scores showed more typical distribution (spine -0.07 ± 1.47, hip 0.02 ± 1.14, femoral neck -0.49 ± 1.31). A higher incidence of osteopenia and/or osteoporosis occurred in males versus females (spine 46.9% versus 31.8%, hip 75.5% versus 18.2% and femoral neck 86.4% versus 45.5%). Multiple regression analysis showed a 50.8% (p < 0.001) reduction in femoral neck BMD with AED usage, after adjustment for age, gender and renal function. Non-traumatic fractures occurred in 27.3% males over 205 patient-years versus 4.6% in females over 149 patient-years, p = 0.095.
CONCLUSIONS: Low bone density was highly prevalent in male patients with increased incidence of non-traumatic fractures. AED usage significantly reduces BMD. Treatment to prevent BMD deterioration will depend on determining the bone turnover status.

Entities:  

Year:  2014        PMID: 25062758      PMCID: PMC4241203          DOI: 10.1007/8904_2014_328

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  27 in total

1.  Osteopenia and osteoporosis: previously unrecognized manifestations of Fabry disease.

Authors:  Dominique P Germain; Karelle Benistan; Pierre Boutouyrie; Celine Mutschler
Journal:  Clin Genet       Date:  2005-07       Impact factor: 4.438

Review 2.  Clinical practice. Osteoporosis in men.

Authors:  Peter R Ebeling
Journal:  N Engl J Med       Date:  2008-04-03       Impact factor: 91.245

Review 3.  Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk?

Authors:  Jennifer E Isenor; Mary H H Ensom
Journal:  Pharmacotherapy       Date:  2010-03       Impact factor: 4.705

Review 4.  Neuroendocrinological aspects of epilepsy: important issues and trends in future research.

Authors:  Alison M Pack; Doodipala Samba Reddy; Susan Duncan; Andrew Herzog
Journal:  Epilepsy Behav       Date:  2011-03-30       Impact factor: 2.937

Review 5.  Reducing fracture risk with calcium and vitamin D.

Authors:  Paul Lips; Roger Bouillon; Natasja M van Schoor; Dirk Vanderschueren; Sabine Verschueren; Natalia Kuchuk; Koen Milisen; Steven Boonen
Journal:  Clin Endocrinol (Oxf)       Date:  2010-09       Impact factor: 3.478

Review 6.  Anti-epileptic medication and bone health.

Authors:  S J Petty; T J O'Brien; J D Wark
Journal:  Osteoporos Int       Date:  2006-11-08       Impact factor: 4.507

7.  BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Authors:  Katie L Stone; Dana G Seeley; Li-Yung Lui; Jane A Cauley; Kristine Ensrud; Warren S Browner; Michael C Nevitt; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

8.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18

Review 9.  Fabry disease.

Authors:  Dominique P Germain
Journal:  Orphanet J Rare Dis       Date:  2010-11-22       Impact factor: 4.123

10.  Association of Fabry's disease with femoral head avascular necrosis.

Authors:  G Ross; F Kuwamura; A Goral
Journal:  Orthopedics       Date:  1993-04       Impact factor: 1.390

View more
  2 in total

1.  Low bone mineral density due to secondary hyperparathyroidism in the GlatmTg(CAG-A4GALT) mouse model of Fabry disease.

Authors:  Hiroki Maruyama; Atsumi Taguchi; Mariko Mikame; Hongmei Lu; Norihiro Tada; Muneaki Ishijima; Haruka Kaneko; Mariko Kawai; Sawako Goto; Akihiko Saito; Riuko Ohashi; Yuji Nishikawa; Satoshi Ishii
Journal:  FASEB Bioadv       Date:  2020-06-10

2.  Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.

Authors:  E R Smith; I Ruderman; S Bruell; K M Nicholls; T D Hewitson; A S Talbot; S G Holt
Journal:  Osteoporos Int       Date:  2022-05-16       Impact factor: 5.071

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.